Maginnis Orthodontics has been acquired by Smile Doctors
October 2020 — Maginnis Orthodontics, Inc. has been sold to Smile Doctors, LLC.
Maginnis Orthodontics is a leading provider of orthodontic care for patients of all ages from pre-teens to adults. The company offers state-of-the-art technologies, including braces and Invisalign®, to create beautiful, healthy smiles. Maginnis is the largest orthodontics group in southern Georgia and coastal South Carolina, with eight office locations.
Smile Doctors, backed by Linden Capital Partners, is the largest orthodontic dental support organization, with more than 160 orthodontic practices across the country. It allows orthodontists to focus exclusively on their patient care while receiving support from experienced professionals committed to the growth and success of their practices.
Our role in the transaction
Oaklins’ teams in Savannah and Jacksonville served as the intermediary and exclusive financial advisors to the seller in this transaction.
Talk to the deal team
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Learn more